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In a diverse group of organisms including plants, Caenorhabditis
elegans, Drosophila, and trypanosomes, double-stranded RNA
(dsRNA) is a potent trigger of gene silencing. In several model
systems, this natural response has been developed into a powerful
tool for the investigation of gene function. Use of RNA interference
(RNAi) as a genetic tool has recently been extended to mammalian
cells, being inducible by treatment with small, 22-nt RNAs that
mimic those produced in the first step of the silencing process.
Here, we show that some cultured murine cells specifically silence
gene expression upon treatment with long dsRNAs (500 nt). This
response shows hallmarks of conventional RNAi including silencing
at the posttranscriptional level and the endogenous production of
22-nt small RNAs. Furthermore, enforced expression of long,
hairpin dsRNAs induced stable gene silencing. The ability to create
stable ‘‘knock-down’’ cell lines expands the utility of RNAi in
mammalian cells by enabling examination of phenotypes that
develop over long time periods and lays the groundwork for by
using RNAi in phenotype-based, forward genetic selections.
The use of genetically tractable model systems has been the keyto our present understanding of gene structure and function,
cell and organismal biology, and, ultimately, the molecular aspects
of human disease. The ability to stably knock out or knock down
gene expression and, thus, function, in particular, has been para-
mount to the use of such models for illuminating biological function.
For example, the use of conditional lethals in bacteriophage T4
allowed functional analysis of phage morphogenesis modules (1),
whereas the same technique applied to yeast permitted the discov-
ery of functional hierarchies among genes regulating cell cycle
progression (2, 3). In both scenarios, cells acquire stable phenotypes
through heritable genetic alterations.
Although such basic genetic approaches are virtually effortless
in many model organisms, cultured mammalian cells have
proven somewhat intractable, in this regard. This is largely
because cultured mammalian cells are diploid and favor nonho-
mologous over homologous recombination. Current approaches
to create stable phenotypes in mammalian cells have been often
met with limited success. Dominant-negative and antisense
strategies have proven inconsistent and unpredictable, thus
lacking experimental rigor equivalent to a point mutation in
yeast. However, one approach now used extensively in other
diploid organisms has the potential to foment a revolution in
mammalian somatic cell genetics. This approach is dubbed
double-stranded RNA (dsRNA)–dependent posttranscriptional
gene silencing, or RNA interference (RNAi).
It has become clear that dsRNA-induced silencing phenomena
are present in evolutionarily diverse organisms including plants,
fungi, and metazoans (reviewed in ref. 4). A combination of
genetic and biochemical studies suggests that many of these
phenomena share a common mechanism. The prevailing model
begins with the conversion of the dsRNA silencing ‘‘trigger’’ into
small RNAs (guide RNAs or siRNAs, ref. 5) that range in size
from 21 to 25 nts, depending on the species of origin (6–8).
These RNAs become incorporated into a multicomponent nu-
clease complex, which uses the sequence of the guidesiRNAs to
identify and destroy homologous mRNAs (7, 8).
In several systems, dsRNA-induced silencing has been harnessed
as a powerful tool for the analysis of gene function. Particularly in
Caenorhabditis elegans, RNAi has emerged as the standard protocol
for quickly assessing the consequences of inhibiting gene function.
In fact, programs are underway to create RNAi libraries that can be
used to suppress, individually, each of the 19,000 genes in the
worm genome (9, 10). In Drosophila, the first evidence of dsRNA-
induced silencing came from the study of embryos (11), and
subsequently, RNAi has proven an effective tool in cultured cells
and in adult insects (7, 12, 13).
Despite its utility in diverse systems, harnessing RNA to study
gene function in mammals seemed potentially problematic. Indeed,
mammals have evolved robust systems for responding to dsRNAs,
specifically as an antiviral defense (reviewed in refs. 14 and 15). In
somatic cells, dsRNA activates a variety of responses. Predominant
among these is PKR, a kinase that is activated by dimerization in the
presence of dsRNA (16). PKR, in turn, phosphorylates EIF2,
causing a nonspecific translational shutdown (reviewed in ref. 14).
dsRNA also activates 2-5 oligoadenylate polymerase, the product
of which is an essential cofactor for a nonspecific ribonuclease,
RNase L (reviewed in ref. 17).
Recently, Tuschl and colleagues (5) have demonstrated that
RNAi can be provoked in numerous mammalian cell lines through
the introduction of siRNAs. These siRNAs avoid provoking the
PKR response by virtue of their small size and are presumed to be
incorporated into the RNAi pathway by mimicking the products of
the Dicer enzyme, which catalyzes the initiation step of RNAi (18).
The ability to apply RNAi in mammals will undoubtedly spark a
firestorm of effort to assess the consequences of suppressing the
expression of genes in cultured mammalian cells.
The power of RNAi as a genetic tool would be greatly
enhanced by the ability to engineer stable silencing of gene
expression. Whereas the production of small RNAs via in vivo
expression is problematic, stable silencing has been induced in
model organisms by directed expression of long dsRNAs (13, 19,
20). We therefore undertook an effort to identify mammalian
cells in which long dsRNAs could be used as RNAi triggers in the
hope that these same cell lines would provide a platform upon
which to develop stable silencing strategies.
Materials and Methods
Cell Culture. P19 mouse embryonic carcinoma cells (American
Type Culture Collection, CRL-1825) were cultured in -MEM
(GIBCOBRL) supplemented with 10% heat-inactivated FBS
and 1% antibioticantimycotic solution (GIBCOBRL). Mouse
embryo stem cells (J1, provided by S. Kim, Cold Spring Harbor
Laboratory) were cultured in DMEM containing ESgro (Chemi-
con) according to the manufacturer’s instructions. C2C12 mu-
rine myoblast cells (gift of N. Tonks, Cold Spring Harbor
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Laboratory) were cultured in DMEM (GIBCOBRL) supple-
mented with 10% heat-inactivated FBS and 1% antibiotic
antimycotic solution (GIBCOBRL).
RNA Preparation. For the production of dsRNA, transcription
templates were generated by PCR; they contained T7 promoter
sequences on each end of the template (see ref. 7). dsRNAs were
prepared by using the RiboMax kit (Ambion, Austin, TX). Firefly
and Renilla luciferase mRNA transcripts were synthesized by using
the Riboprobe kit (Promega) and were gel purified before use.
Transfection and Gene Silencing Assays. Cells were transfected with
indicated amounts of dsRNA and plasmid DNA by using Fu-
GENE6 (Roche Biochemicals) according to the manufacturer’s
instructions. Cells were transfected at 50–70% confluence in 12-
well plates containing either 1 or 2 ml of medium per well. Dual
luciferase assays (Promega) were carried out by cotransfecting cells
with plasmids contain firefly luciferase under the control of SV40
promoter (pGL3-Control, Promega) and Renilla luciferase under
the control of the SV40 early enhancerpromoter region (pSV40,
Promega). These plasmids were cotransfected by using a 1:1 or 10:1
ratio of pGL3-control (250 ngwell) to pRL-SV40. Both ratios
yielded similar results. For some experiments, cells were transfected
with vectors that direct expression of enhanced green fluorescent
protein (EGFP)-US9 fusion protein (21) or red fluorescent protein
(pDsRed N1, CLONTECH). RNAi in S2 cells was performed as
described (7).
Plasmids expressing hairpin RNAs (RNAs with a self-
complimentary stem loop) were constructed by cloning the first
500 bp of the EGFP coding region (CLONTECH) into the FLIP
cassette of pRIP-FLIP (E. Bernstein and G.J.H., unpublished
data) as a direct repeat. The FLIP cassette contains two direc-
tional cloning sites, the second of which sports f lanking LoxP
sites (see Fig. 6A). The Zeocin gene (Stratagene), present
between the cloning sites, maintains selection and, thus, stability
of the FLIP cassette. The FLIP cassette containing EGFP direct
repeats was subcloned into pcDNA3 (Invitrogen). To create an
inverted repeat for hairpin production, EGFP direct repeat
clones were exposed to Cre recombinase (Stratagene) in vitro
and, afterward, transformed into DL759 Escherichia coli (22).
These bacteria permit the replication of DNA containing cru-
ciform structures, which tend to form from inverted repeats.
DL759 transformants were screened for plasmids containing
inverted repeats (50%).
Silencing of Dicer was accomplished by using a dsRNA
comprising exon 25 of the mouse Dicer gene and corresponding
to nucleotides 5284–5552 of the human Dicer cDNA.
In Vitro Translation and in Vitro Dicer Assays. Logarithmically grow-
ing cells were harvested in PBS containing 5 mM EGTA washed
twice in PBS and once in hypotonic buffer (10 mM Hepes, pH 7.36
mM -mercaptoethanol). Cells were suspended in 0.7 packed-cell
Fig. 1. RNAi in P19 embryonal carcinoma cells. Ten-centimeter plates of P19
cells were transfected by using 5g of GFP plasmid and 40g of the indicated
dsRNA (or no RNA). Cells were photographed by fluorescent and phase-
contrast microscopy at 72 h after transfection; silencing was also clearly
evident at 48 h posttransfection.
Fig. 2. RNAi of firefly and Renilla luciferase in P19 cells. (A) P19 cells were
transfected with plasmids that direct the expression of firefly and Renilla
luciferase and dsRNA 500 mers (25 or 250 ng, as indicated), that were either
homologous to the firefly luciferase mRNA (dsFF) or nonhomologous (dsGFP).
Luciferase activities were assayed at various times after transfection, as indi-
cated. Ratios of firefly to Renilla activity are normalized to dsGFP controls. (B
and C) P19 cells in 12-well culture dishes (2 ml of media) were transfected with
0.25 g of a 9:1 mix of pGL3-Control and pRL-SV40 as well as 2 g of the
indicated RNA. Extracts were prepared 9 h after transfection. (B) Ratio of
firefly to Renilla luciferase is shown. (C) Ratio of Renilla to firefly luciferase is
shown. Values are normalized to dsGFP. The average of three independent
experiments is shown; error bars indicate standard deviation.
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volumes of hypotonic buffer containing Complete protease inhibi-
tors (Roche Molecular Biochemicals) and 0.5 unitsml of RNasin
(Promega). Cells were disrupted in a Dounce homogenizer with a
type B pestle, and lysates were centrifuged at 30,000 g for 20 min.
Supernatants were used in an in vitro translation assay containing
capped m7G(5)pppG firefly and Renilla luciferase mRNA or in in
vitro Dicer assays containing 32P-labeled dsRNA. For in vitro
translation assays, 5 l of extract were mixed with 100 ng of firefly
and Renilla mRNA along with 1 g of dsRNA (or buffer)10 mM
DTT0.5 mM spermidine200 mM Hepes, 3.3 mM MgOAc800
mM KOAc1 mM ATP1 mM GTP4 units of Rnasin215 g of
creatine phosphate1 g of creatine phosphate kinase1 mM
amino acids (Promega). Reactions were carried out for 1 h at 30°C
and quenched by adding 1 passive lysis buffer (Promega). Extracts
were then assayed for luciferase activity. In vitro assays for Dicer
activity were performed as described (18).
Construction of Stable Silencing Lines. Ten-centimeter plates of P19
cells were transfected with 5 g of GFP hairpin expression
plasmid and selected for stable integrants by using G-418 (300
ngml) for 14 days. Clones were selected and screened for
silencing of GFP.
Results
RNAi in Pluripotent Murine P19 Cells. It has long been clear that the
nonspecific responses to dsRNA are attenuated during early
development. In fact, injection of dsRNA into early-stage mouse
embryos can induce sequence-specific silencing of both exoge-
nous and endogenous genes (23, 24). Consistent with the pos-
sibility that RNAi might extend to mammals, homologs of the
proteins that participate in this response can be easily identified
in the mouse and human genomes (reviewed in ref. 4).
We sought to determine whether long dsRNA triggers could
induce sequence-specific silencing in cultured murine cells, both
to develop this approach as a tool for probing gene function and
to allow mechanistic studies of dsRNA-induced silencing to be
propagated to mammalian systems. We, therefore, attempted to
extend previous studies in mouse embryos (23, 24) by searching
for RNAi-like mechanisms in pluripotent, embryonic cell types.
We surveyed a number of cell lines of embryonic origin for the
degree to which generalized suppression of gene expression
occurred upon introduction of dsRNA. As an assay, we tested the
effects of dsRNA on the expression of GFP as measured in situ
by counting fluorescent cells. As expected, in both human
embryonic kidney cells (293) and mouse embryo fibroblasts,
GFP expression was virtually eliminated irrespective of the
sequence of the cotransfected dsRNA (not shown). In some
pluripotent teratocarcinoma and teratoma cell lines (e.g., N-
Tera1, F9), the PKR response was attenuated but still evident
(not shown); however, in contrast, transfection of nonhomolo-
gous dsRNAs had no effect on the expression of reporter genes
(e.g., GFP, luciferase) either in mouse embryonic stem cells (not
shown) or in p19 embryonal carcinoma cells (Fig. 1).
Transfection of P19 embryonal carcinoma cells with GFP in the
presence of cognate dsRNA corresponding to the first 500 nts of
the GFP coding sequence had a strikingly different effect. GFP
expression was eliminated in the vast majority of cotransfected cells
(Fig. 1), suggesting that these cultured murine cells might respond
Fig. 3. Specific silencing of luciferase expression by dsRNA in murine em-
bryonic stem cells. Mouse embryonic stem cells in 12-well culture dishes (1 ml
of media) were transfected with 1.5 g of dsRNA along with 0.25 g of a 10:1
mixture of the reporter plasmids pGL3-Control and pRL-SV40. Extracts were
prepared and assayed 20 h after transfection. The ratio of firefly to Renilla
luciferase expression is shown for FF ds500; the ratio of Renilla to firefly is
shown for Ren ds500. Both are normalized to ratios from the dsGFP transfec-
tion. The average of three independent experiments is shown; error bars
indicate standard deviation.
Fig. 4. RNAi in C2C12 murine myoblast cells. (A) Mouse C2C12 cells in 12-well
culture dishes (1 ml of media) were transfected with 1 g of the indicated
dsRNA along with 0.250 g of the reporter plasmids pGL3-Control and pRL-
SV40. Extracts were prepared and assayed 24 h after transfection. The ratio of
firefly to Renilla luciferase expression is shown; values are normalized to ratios
from the no dsRNA control. The average of three independent experiments is
shown; error bars indicate standard deviation. (B) C2C12 cells cotransfected
with 1 g of either plasmid alone or a plasmid containing a hyperactive
mutant of vaccinia virus K3L (26). The absolute counts of Renilla and firefly
luciferase activity are shown. (C) The ratios of fireflyRenilla activity from B,
normalized to no dsRNA controls.
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to dsRNA in a manner similar to that which we had previously
demonstrated in cultured, Drosophila S2 cells (7).
To quantify the extent to which dsRNA could induce sequence-
specific gene silencing, we used a dual luciferase reporter assay
similar to that which had first been used to demonstrate RNAi in
Drosophila embryo extracts (25). P19 EC cells were transfected with
a mixture of two plasmids that individually direct the expression of
firefly luciferase and Renilla luciferase. These were cotransfected
with no dsRNA, with dsRNA that corresponds to the first500 nts
of the firefly luciferase, or with dsRNA corresponding to the first
500 nts of GFP as a control. Cotransfection with GFP dsRNA
gave luciferase activities that were similar to the no-dsRNA control,
both in the fireflyRenilla activity ratio and in the absolute values
of both activities. In contrast, in cells that received the firefly
luciferase dsRNA, the ratio of firefly to Renilla luciferase activity
was reduced by up to 30-fold (250 ng, Fig. 2B). For comparison, we
carried out an identical set of experiments in Drosophila S2 cells.
Although qualitatively similar results were obtained, the silencing
response was more potent. At equivalent levels of dsRNA, S2 cells
suppressed firefly luciferase activity to virtually background levels
(not shown).
The complementary experiment, in which dsRNA was homol-
ogous to Renilla luciferase, was also performed. Again, in this
case, suppression of the expression of the Renilla enzyme was
10-fold (Fig. 2D). Thus, the dsRNA response in P19 cells was
flexible, and the silencing machinery was able to adapt to
dsRNAs directed against any of the reporters that were tested.
We took two approaches to test whether this response was
specific for dsRNA. Pretreatment of the trigger with purified
RNase III, a dsRNA-specific ribonuclease, before transfection
Fig. 5. Expression of a hairpin RNA produces P19 EC cell lines that stably silence GFP. (A) A cartoon of the FLIP cassette used to construct the GFP hairpin. GFP
represents the first 500 coding base pairs of EGFP. Zeo, zeocin resistance gene; L, Lox; P, the cytomegalovirus promoter in the expression plasmid pcDNA3.
Homologous GFP fragments are first cloned as direct repeats into the FLIP cassette. To create inverted repeats for hairpin production, the second repeat is flipped
by using Cre recombinase. When transcribed, the inverted repeat forms a GFP dsRNA with a hairpin loop. (B) P19 cell lines stably expressing the GFP hairpin
plasmid, GFPhp.1 (clone 10) and GFPhp.2 (clone 12), along with wt P19 were transfected with 0.25 g each of GFP and RFP reporter genes. Fluorescence
micrographs were taken by using filters appropriate for GFP and RFP. Magnification is 200. (C) P19 GFPhp.1 cells were transfected with pEGFP and 0, 0.5, or
1 g of Dicer or firefly dsRNA. Fluorescence micrographs were taken at 48 h posttransfection and are superimposed with bright field images to reveal non-GFP
expressing cells. Magnification is 100. (D) In vitro and in vivo processing of dsRNA in P19 cells. In vitro Dicer assays were performed on S2 cells and three
independently prepared P19 extracts by using 32P-labeled dsRNA (30°C for 30 min). A Northern blot of RNA extracted from control and GFPhp.1 P19 cells shows
the production of 22mer RNA species in hairpin-expressing cells but not in control cells. Blots were probed with a 32P-labeled ‘‘sense’’ GFP transcript.
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greatly reduced its ability to provoke silencing (not shown).
Furthermore, transfection of cells with single-stranded antisense
RNAs directed against either firefly or Renilla luciferase had
little or no effect on expression of the reporters (Fig. 2 C and D).
Considered together, these results provided a strong indication
that double-stranded RNAs provoke a potent and specific
silencing response in P19 embryonal carcinoma cells.
Efficient silencing could be provoked with relatively low con-
centrations of dsRNA (25 ngml culture media; see Fig. 2A). The
response was concentration-dependent, with maximal suppression
of 20-fold being achieved at a dose of 1.5 gml culture media.
Silencing was established rapidly and was evident by 9 h post-
transfection (the earliest time point examined). Furthermore, the
response persisted without significant changes in the degree of
suppression for up to 72 h following a single dose of dsRNA.
RNAi in Embryonic Stem Cells. To assess whether the presence of a
sequence-specific response to dsRNA was a peculiarity of P19
cells or whether it also extended to normal murine embryonic
cells, we performed similar silencing assays in mouse embryonic
stem cells. Cotransfection of embryonic stem cells with noncog-
nate dsRNAs (e.g., GFP), again, had no dramatic effect on either
the absolute values or the ratios of Renilla and firefly luciferase
activity (Fig. 3). However, transfection with either firefly or
Renilla luciferase dsRNA dramatically and specifically reduced
the activity of the targeted enzyme (Fig. 3).
This result suggests that RNAi can operate in multiple murine
cell types of embryonic origin, including normal embryonic stem
cells. The ability to provoke silencing in a cell type that is
normally used for the generation of genetic, mosaic animals
suggests the possibility of eventually testing the biological effects
of silencing both in culture and in reconstituted animal models.
RNAi in Murine Somatic Cells. RNAi effector pathways are likely to
be present in mammalian somatic cells, based on the ability of
siRNAs to induce transient silencing (5). Furthermore, we have
shown that RNAi initiator and effector pathways clearly exist in
embryonic cells that can enforce silencing in response to long
dsRNA triggers. We therefore sought to test whether the RNAi
machinery might exist intact in some somatic cell lines.
Transfection of HeLa cells with luciferase reporters in combi-
nation with long dsRNA triggers caused a nearly complete sup-
pression of activity, irrespective of the RNA sequence. In a murine
myoblast cell line, C2C12, we noted a mixture of two responses.
dsRNAs homologous to firefly luciferase provoked a sequence-
specific effect, producing a degree of suppression that was slightly
more potent than was observed upon transfection with cognate
21-nt siRNA (ref. 5; Fig. 4A). However, with long dsRNA triggers,
the specific effect was superimposed upon a generalized suppres-
sion of reporter gene expression that was presumably because of
PKR activation (Fig. 4B).
Numerous mammalian viruses have evolved the ability to
block PKR as an aid to efficient infection. For example, adeno-
viruses express VA RNAs, which mimic dsRNA with respect to
binding but not to activation of PKR (16). Vaccinia virus uses
two strategies to evade PKR. First is expression of E3L, which
binds and masks dsRNAs (26). The second is expression of K3L,
which binds and inhibits PKR via its ability to mimic the natural
substrate of this enzyme, eIF2 (26).
Transfection of C2C12 cells with a vector that directs K3L
expression attenuates the generalized repression of reporter
genes in response to dsRNA. However, this protein had no effect
on the magnitude of specific inhibition by RNAi (Fig. 4C).
These results raise the possibility that, at least in some cell lines
andor cell types, blocking nonspecific responses to dsRNA will
enable the use of long dsRNAs for the study of gene function. This
might be accomplished through the use of viral inhibitors, as
described here, or through the use of cells isolated from animals
that are genetically modified to lack undesirable responses.
Stable Suppression of Gene Expression Using RNAi. To date, dsRNAs
have been used to induce sequence-specific gene silencing in
either cultured mammalian cells or in embryos only in a transient
fashion. However, the most powerful applications of genetic
manipulation are realized only with the creation of stable
mutants. The ability to induce silencing by using long dsRNAs
offers the opportunity to translate into mammalian cells work
from model systems such as Drosophila, plants, and C. elegans
wherein stable silencing has been achieved by enforced expres-
sion of hairpin RNAs (13, 19, 20).
P19 EC cells were transfected with a control vector or with an
expression vector that directs expression of a 500-nt GFP
hairpin RNA from an RNA polymerase II promoter (cytomeg-
alovirus). Colonies arising from cells that had stably integrated
either construct were selected and expanded into clonal cell
lines. Each cell line was assayed for persistent RNAi by transient
cotransfection with a mixture of two reporter genes, dsRED to
mark transfected cells and GFP to test for stable silencing.
Transfection of clonal P19 EC cells that had stably integrated
the control vector produced equal numbers of red and green
cells, as would be expected in the absence of any specific
silencing response (Fig. 5B), whereas cells that express the GFP
hairpin RNA gave a very different result. These cells expressed
the dsRED protein with an efficiency comparable to that
observed in cells containing the control vector. However, the
cells failed to express the cotransfected GFP reporter (Fig. 5B).
These data provide a strong indication that continuous expres-
sion of a hairpin dsRNA can provoke stable, sequence-specific
silencing of a target gene.
In Drosophila S2 cells and C. elegans (18, 27–30), RNAi is
initiated by the Dicer enzyme, which processes dsRNA into22-nt
siRNAs (18). In both, S2 cells and C. elegans experiments by using
dsRNA to target Dicer suppress the RNAi response (18, 27, 29).
Whether Dicer plays a central role in hairpin-induced gene silencing
in P19 cells was tested by transfecting P19 cells stably transfected
with GFP hairpin constructs with mouse Dicer dsRNA (see Mate-
rials and Methods). Treatment with Dicer dsRNA, but not control
dsRNA, resulted in derepression of GFP (Fig. 5C).
dsRNA Induces Posttranscriptional Silencing. A key feature of RNAi
is that it exerts its effect at the posttranscriptional level by
destruction of targeted mRNAs (reviewed in ref. 4). To test
Fig. 6. dsRNA induces silencing at the posttranscriptional level. P19 cell
extracts were used for in vitro translation of firefly and Renilla luciferase
mRNA (100 ng each). Translation reactions were programmed with various
amounts of dsRNA 500mers, either homologous to firefly luciferase mRNA
(dsLUC) or nonhomologous (dsGFP). Luciferase assays were carried out after a
1-h incubation at 30°C. Ratios of firefly to Renilla activity are normalized to no
dsRNA controls. Standard deviations from the mean are shown.
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whether dsRNAs induced silencing in mouse cells via posttran-
scriptional mechanisms, we used an assay identical to that, used
initially to characterize RNAi responses in Drosophila embryo
extracts (25). We prepared lysates from P19 EC cells that were
competent for in vitro translation of capped mRNAs correspond-
ing to Renilla and firefly luciferase. Addition of nonspecific
dsRNAs to these extracts had no substantial effect on either the
absolute amount of luciferase expression or on the ratio of firefly
to Renilla luciferase (Fig. 6). In contrast, addition of dsRNA
homologous to the firefly luciferase induced a dramatic and
dose-dependent suppression of activity. Addition of RNA cor-
responding to only the antisense strand of the dsRNA had little
effect, comparable to a nonspecific dsRNA control, and pre-
treatment of the dsRNA silencing trigger with RNase III greatly
reduced its potential to induce silencing in vitro. A second
hallmark of RNAi is the production of small, 22-nt siRNAs,
which determine the specificity of silencing. We found that such
RNA species were generated from dsRNA in P19 cell extracts
(Fig. 5D, in vitro), indicative of the presence of a mouse Dicer
activity. These species were also produced in cells that stably
express GFP hairpin RNAs (Fig. 5D, in vivo). Considered
together, the posttranscriptional nature of dsRNA-induced si-
lencing, the association of silencing with the production of
22-nt siRNAs, and the dependence of this response on Dicer,
a key player in the RNAi pathway, strongly suggests that dsRNA
suppresses gene expression in murine cells via a conventional
RNAi mechanism.
Discussion
The discovery that dsRNA could induce gene silencing in
organisms as diverse as plants and parasitic protozoans has
raised the possibility that RNAi might be a nearly universal
mechanism of gene silencing. This notion has been supported by
the identification of homologs of proteins that participate in the
silencing process in virtually all genomes examined to date, with
the exception of Saccharomyces cerevisiae (reviewed in ref. 4).
The first indications that this response might also extend to
mammals came from the observation that injection of dsRNAs
into early mouse embryos induced sequence-specific silencing
(23, 24). Recent work by Tuschl and colleagues (5) had shown
that siRNAs can induce silencing in numerous mammalian cell
lines, presumably by entering the RNAi pathway. However, both
in mouse embryos and previous mammalian cell culture studies,
silencing was transient.
As an extension of these pioneering studies, we have demon-
strated that dsRNA can induce potent and specific gene silencing
in mouse embryonic cell lines. Specifically, we have shown that
silencing can be induced by long dsRNAs in mouse embryonal
carcinoma cell lines, in normal mouse embryonic stem cells, and
in some mouse somatic cells. There are several indications that
this phenomenon might be mechanistically related to RNA
interference pathways that have been characterized in plants, C.
elegans, and Drosophila. First, induction of silencing requires
dsRNA. Second, in vitro studies suggest that silencing occurs at
the posttranscriptional level. Third, silencing is correlated with
the appearance of 22-nt siRNAs homologous to the gene that
is being suppressed. However, final placement of the phenom-
enon reported here within the pantheon of dsRNA-induced
silencing mechanisms will require a characterization of the
protein andor ribonucleoprotein machinery, which enforces
suppression. A significant step toward this goal has been taken
by the demonstration that Dicer is required for dsRNA-induced
silencing in P19 cells.
We have demonstrated that stable, sequence-specific silencing
can be induced by enforcing endogenous expression of RNA
hairpins. The ability to create permanent cell lines with a desired
loss-of-function phenotype extends the utility of RNAi as
method for probing gene function in mammalian cells. This
capability enables the production of large numbers of silenced
cells for biochemical analysis and permits the evaluation of
phenotypes over long time spans. However, perhaps the two
most important ramifications of stable RNAi are the ability to
harness this technology for unbiased, phenotype-based genetic
selections and the possibility that stably silenced, embryonic cell
lines might ultimately be used to reconstitute animals containing
a specifically silenced locus.
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